CGNT(CGNT)
CGNT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $446M | $492M | $453M |
| Low | $439M | $485M | $447M |
| High | $449M | $496M | $456M |
| EBITDA Avg | $67M | $107M | — |
| Low | $66M | $106M | — |
| High | $68M | $108M | — |
| EBIT Avg | $54M | $93M | — |
| Low | $54M | $92M | — |
| High | $55M | $95M | — |
| Net Income Avg | $33M | $56M | — |
| Low | $32M | $55M | — |
| High | $33M | $57M | — |
| EPS Avg | $0.45 | $0.77 | — |
| Low | $0.44 | $0.76 | — |
| High | $0.45 | $0.78 | — |
| Analysts (Rev / EPS) | 3 / 2 | 2 / 1 | 1 / — |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|
| Revenue Avg | $113M | $119M | $116M | $119M | $125M | $132M |
| Low | $112M | $118M | $115M | $118M | $124M | $131M |
| High | $115M | $120M | $118M | $121M | $127M | $133M |
| EBITDA Avg | $21M | $25M | $23M | $24M | $27M | $33M |
| Low | $21M | $25M | $23M | $24M | $27M | $32M |
| High | $21M | $25M | $23M | $25M | $27M | $33M |
| EBIT Avg | $18M | $22M | $20M | $21M | $24M | $29M |
| Low | $17M | $22M | $20M | $21M | $23M | $29M |
| High | $18M | $22M | $20M | $21M | $24M | $30M |
| Net Income Avg | $11M | $13M | $12M | $13M | $14M | $18M |
| Low | $10M | $13M | $12M | $12M | $14M | $17M |
| High | $11M | $13M | $12M | $13M | $14M | $18M |
| EPS Avg | $0.14 | $0.18 | $0.16 | $0.17 | $0.20 | $0.24 |
| Low | $0.14 | $0.18 | $0.16 | $0.17 | $0.19 | $0.24 |
| High | $0.15 | $0.18 | $0.16 | $0.18 | $0.20 | $0.24 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |